Get started
Award

PMP15/00027

Funded outputs count: 10
Funder award ID: PMP15/00027
OpenAlex ID: G2165916640
Cost-effectiveness of personalized medical treatment in acromegaly: a post hoc analysis of the ACROFAST study
2026 · Montserrat Marques-Pamies, Laura Ricou, et al. · Journal of the Endocrine Society · 3
Correction to “Magnetic Resonance Imaging as a Predictor of Therapeutic Response to Pasireotide in Acromegaly”
2024 · Clinical Endocrinology · 1
PDF
Personalized Medicine in Acromegaly: The ACROFAST Study
2024 · Montserrat Marques-Pamies, Joan Gil, et al. · The Journal of Clinical Endocrinology & Metabolism · 34
PDF
Predictors of biochemical response to somatostatin receptor ligands in acromegaly
2024 · Mónica Marazuela, Rebeca Martínez-Hernandez, et al. · Best Practice & Research Clinical Endocrinology & Metabolism · 24
PDF
Predictors of Response to Treatment with First-Generation Somatostatin Receptor Ligands in Patients with Acromegaly
2023 · Montserrat Marques-Pamies, Joan Gil, et al. · Archives of Medical Research · 21
PDF
Magnetic resonance imaging as a predictor of therapeutic response to pasireotide in acromegaly
2023 · Sabina Ruiz, Joan Gil, et al. · Clinical Endocrinology · 29
PDF
Molecular characterization of epithelial-mesenchymal transition and medical treatment related-genes in non-functioning pituitary neuroendocrine tumors
2023 · Joan Gil, Montserrat Marques-Pamies, et al. · Frontiers in Endocrinology · 11
PDF
Implications of Heterogeneity of Epithelial-Mesenchymal States in Acromegaly Therapeutic Pharmacologic Response
2022 · Joan Gil, Montserrat Marques-Pamies, et al. · Biomedicines · 16
PDF
Molecular profiling for acromegaly treatment: a validation study
2020 · Manel Puig-Domingo, Joan Gil, et al. · Endocrine Related Cancer · 75
PDF